Abolis Launches MINE Microbial Data Platform for Fragrance

Abolis Biotechnologies has launched the MINE platform, evolved from its internal Microbiome Studio tool to support external R&D and open innovation in microbial biotechnology. The French biotechnology company's Microbial Intelligence Explorer (MINE) platform makes microbial data actionable for industrial innovation in fragrance ingredient development.

This launch addresses a growing industry need to translate complex microbial data into practical development steps for sustainable and high-performance ingredients. The foundations of MINE were laid through Microbiome Studio, a machine learning-enabled analytical platform created from the Metapath project, an industrial programme supported by the French government. Initially built for Abolis' own microbial biotechnology programmes and refined through industrial collaborations, Microbiome Studio has now been developed into MINE for external use.

How MINE works for industrial users

MINE integrates microbial and multi-omics data with experimental and industrial insight to help teams interpret complex biological systems and prioritise development efforts. The platform brings together genomic exploration, multi-omics analysis and experimental interpretation. It makes microbial data more accessible to R&D and open innovation teams without requiring every decision maker to be an omics or bioinformatics specialist.

Generating biological data is only part of the challenge. The bigger challenge is interpreting that data to determine which metabolic mechanisms, parameters and development pathways warrant further investigation. MINE was built with industrial users to address this data interpretation gap. It enables teams to examine how individual strains contribute to the production of molecules of interest and to investigate interactions within complex microbial systems. The platform helps identify relevant biological mechanisms, potential levers for process optimisation, and validation requirements. It links biological findings to technical and industrial constraints, directing resources towards development routes with the strongest supporting evidence.

Applications and strategic value

The platform supports applications across cosmetics and personal care, enabling the development of fragrance ingredients, biotics, and fermentation-derived products by linking biological findings to industrial feasibility. Microbial systems hold significant potential for industries seeking new approaches to product performance, supply chain resilience and more sustainable production methods.

MINE connects microbial intelligence with Abolis' capabilities in strain engineering, enzyme modelling, fermentation, bioprocess development and scale-up. This allows partners to assess biological potential and industrial feasibility within the same development programme. The launch of MINE expands Abolis' ideation-to-scale model and builds on the company's wider focus on making microbial biotechnology more industrially actionable. Beyond cosmetics, the platform also supports applications across pharma and healthcare, food, nutrition and agriculture.

Leadership and vision

Sylvia Julien, General Manager of the MINE Business Unit at Abolis Biotechnologies, emphasises that MINE helps teams handle complexity in microbial biotechnology by focusing on signals most likely to advance product development. She stated that the challenge in microbial biotechnologies lies in the difficulty of integrating various pieces of information and knowing which signals matter for product development. MINE gives teams a clearer way to handle that complexity, helping them focus experimental work on the questions most likely to move a programme forward.

The platform was developed specifically to address the gap in identifying which biological mechanisms and parameters are relevant at the metabolic level for microbial ingredient discovery. MINE enables partners to interpret biological evidence in the context of product objectives and technical requirements. It helps focus development efforts on the most credible routes to industrialisation. MINE enables partners to assess biological potential and industrial feasibility within the same development programme, expanding Abolis' ideation-to-scale model.